157 related articles for article (PubMed ID: 21108444)
21. A cautionary note regarding hydroxyurea in sickle cell disease.
Vichinsky EP; Lubin BH
Blood; 1994 Feb; 83(4):1124-8. PubMed ID: 7509209
[TBL] [Abstract][Full Text] [Related]
22. Fetal hemoglobin in sickle cell anemia: a glass half full?
Steinberg MH; Chui DH; Dover GJ; Sebastiani P; Alsultan A
Blood; 2014 Jan; 123(4):481-5. PubMed ID: 24222332
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
Rodgers GP
Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
[TBL] [Abstract][Full Text] [Related]
24. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease.
Maier-Redelsperger M; de Montalembert M; Flahault A; Neonato MG; Ducrocq R; Masson MP; Girot R; Elion J
Blood; 1998 Jun; 91(12):4472-9. PubMed ID: 9616141
[TBL] [Abstract][Full Text] [Related]
25. Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium.
Haynes J; Obiako B; Hester RB; Baliga BS; Stevens T
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H379-85. PubMed ID: 17993595
[TBL] [Abstract][Full Text] [Related]
26. Comparison of radial immunodiffusion and alkaline cellulose acetate electrophoresis for quantitating elevated levels of fetal hemoglobin (HbF): application to evaluating patients with sickle cell disease treated with hydroxyurea.
Schultz JC
J Clin Lab Anal; 1999; 13(2):82-9. PubMed ID: 10102137
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of F cells in sickle cell disorders by flow cytometry -- comparison with the Kleihauer-Betke's slide method.
Italia KY; Colah R; Mohanty D
Int J Lab Hematol; 2007 Dec; 29(6):409-14. PubMed ID: 17988294
[TBL] [Abstract][Full Text] [Related]
28. Measurements of red cell deformability and hydration reflect HbF and HbA
Parrow NL; Tu H; Nichols J; Violet PC; Pittman CA; Fitzhugh C; Fleming RE; Mohandas N; Tisdale JF; Levine M
Blood Cells Mol Dis; 2017 Jun; 65():41-50. PubMed ID: 28472705
[TBL] [Abstract][Full Text] [Related]
29. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS
Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
Charache S
Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
[TBL] [Abstract][Full Text] [Related]
31. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
[TBL] [Abstract][Full Text] [Related]
32. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
[TBL] [Abstract][Full Text] [Related]
33. Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
Lapouméroulie C; Benkerrou M; Odièvre MH; Ducrocq R; Brun M; Elion J
Haematologica; 2005 Mar; 90(3):401-3. PubMed ID: 15749673
[TBL] [Abstract][Full Text] [Related]
34. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
[TBL] [Abstract][Full Text] [Related]
35. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia.
Orringer EP; Blythe DS; Johnson AE; Phillips G; Dover GJ; Parker JC
Blood; 1991 Jul; 78(1):212-6. PubMed ID: 1712641
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.
Tolu SS; Crouch A; Choi J; Gao Q; Reyes-Gil M; Ogu UO; Vinces G; Minniti CP
Ann Hematol; 2022 Mar; 101(3):541-548. PubMed ID: 35039901
[TBL] [Abstract][Full Text] [Related]
37. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
[TBL] [Abstract][Full Text] [Related]
38. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
[TBL] [Abstract][Full Text] [Related]
39. Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: implications for pharmacological intervention.
Marcus SJ; Ware RE
J Pediatr Hematol Oncol; 1999; 21(5):407-11. PubMed ID: 10524455
[TBL] [Abstract][Full Text] [Related]
40. Erythroid progenitors in the peripheral blood of children with sickle cell disease.
West TB; Ohene-Frempong K; Stoeckert CJ; Surrey S
Am J Pediatr Hematol Oncol; 1994 May; 16(2):116-9. PubMed ID: 7513134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]